International trends in rigid contact lens prescribing (2000–2023): An update
Contact Lens and Anterior Eye · 2024-10 · 47 (5) · 102255
DOI: 10.1016/j.clae.2024.102255 ↗Kurz gefasst
Multizentrische Studie in der Zeitschrift Contact Lens and Anterior Eye, 2024-10. Verfasst von Nathan Efron und 5 weiteren Autor:innen. Beteiligte Einrichtung: Optometry and Vision Science, Queensland University of Technology, Kelvin Grove, Queensland, Australia. Electronic address: n.efron@qut.edu.au. Hauptthemen laut MEDLINE: Contact Lenses, Prescriptions, Prosthesis Fitting. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 15 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
PURPOSE: Rigid contact lenses have an important role in contact lens practice. The purpose of this work is to update earlier surveys by describing global trends in rigid lens fitting between 2000-2023. METHOD: An annual contact lens prescribing survey was sent to eye care practitioners in up to 71 countries between 2000 and 2023. Data relating to 342,500 fits undertaken in 20 countries returning reliable longitudinal data were analysed in respect of rigid lens fitting, defined as the fitting of any design of a contact lens manufactured in a rigid material. RESULTS: Overall, rigid lens prescribing increased slightly over time, from 14.2 % of lens fits in 2000 to 15.2 % in 2023 (p < 0.0001). However, post-hoc analysis shows that the change over time is best described as a decline between 2000 and 2012, followed by a steady increase subsequently. There were significant differences in rigid lens prescribing between countries (p < 0.0001). The difference between the percentage of males fitted with rigid lenses, as a proportion of all contact lenses (12.7 %), and females (12.0 %) is significant (p < 0.0001), although not clinically meaningful. Rigid lens wearers are older at fitting than soft lens wearers (38.7 vs 31.3 years, respectively) (p < 0.0001). Analysis of 5,994 rigid lens fits prescribed currently (2019-2023) were categorised as: corneal sphere - 30 %; scleral and corneo-scleral - 28 %; corneal myopia control/orthokeratology - 21 %; and corneal complex (including toric, multifocal and monovision) - 16 %. CONCLUSION: There has been a slight increase in rigid lens fitting during the second decade of this century. This increase is apparently due to a 'repurposing' of rigid lenses, with the growth of scleral/corneo-scleral and myopia control/orthokeratology lens fits essentially replacing conventional spherical corneal lens fits.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Optometry and Vision Science, Queensland University of Technology, Kelvin Grove, Queensland, Australia. Electronic address: n.efron@qut.edu.au.
- Eurolens Research, Division of Pharmacy and Optometry, University of Manchester, United Kingdom.
- Department of Optometry and Visual Science, UNSW Sydney, Sydney, Australia.
- Centre for Ocular Research & Education (CORE), School of Optometry and Vision Science, University of Waterloo, Waterloo, Ontario, Canada.
- School of Optometry, The University of Alabama at Birmingham, Birmingham, AL, USA.
Zitieren
APA
Efron, N., Morgan, P. B., Woods, C. A., Jones, D., Jones, L., & Nichols, J. J. (2024). International trends in rigid contact lens prescribing (2000–2023): An update. Contact Lens and Anterior Eye, 47(5), 102255. https://doi.org/10.1016/j.clae.2024.102255
Vancouver
Efron N, Morgan PB, Woods CA, Jones D, Jones L, Nichols JJ. International trends in rigid contact lens prescribing (2000–2023): An update. Contact Lens and Anterior Eye. 2024;47(5):102255. doi:10.1016/j.clae.2024.102255
BibTeX
@article{Efron2024,
author = {Efron, Nathan and Morgan, Philip B and Woods, Craig A and Jones, Deborah and Jones, Lyndon and Nichols, Jason J},
title = {International trends in rigid contact lens prescribing (2000–2023): An update},
journal = {Contact Lens and Anterior Eye},
year = {2024},
volume = {47},
number = {5},
pages = {102255},
doi = {10.1016/j.clae.2024.102255}
}
EUVIMED